FDA Inspection
Rubicon Research Private LimitedRubicon Research Private Limited – FDA Inspection, Mar 8, 2024
Record Details
This FDA Inspection record concerns Rubicon Research Private Limited, with an inspection on March 8, 2024, issued by the Center for Drug Evaluation and Research.
- Inspection Date
- March 8, 2024
View Company Profile
ID · f00f8404-7177-4b65-bf89-298c4f087c92
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1231826
- FDA center
- Human Drugs
- Project area
- New Drug Evaluation
FDA Citations
1- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Rubicon Research Private Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2024 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| January 27, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 30, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| November 20, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 13, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Rubicon Research Private Limited
- FDA Inspection 1250746 - 2024-11-07
- FDA Inspection 1195651 - 2023-01-27
- FDA Inspection 1102226 - 2019-08-30
- FDA Inspection 1038536 - 2017-11-20
- FDA Inspection 924394 - 2015-03-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.